HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 10, October 2019 – Disruptive Urban Farming — Microbes, Plasmids, and Recycling       » Chinese scientist find new possibilities in dengue virus control       » 50 young scientists awarded with the inaugural XPLORER PRIZE       » Entering the China market to provide regional support       » Science, Tech, and policies convene for a sustainable future      
BIOBOARD For e-subscribers (PDF)
Vol 23, No. 08, August 2019
ASIA-PACIFIC
MIT's research enterprise in Singapore (SMART) launches new research group, boosting nation's cell therapy R&D

New research group launched by SMART, Critical Analytics for Manufacturing Personalized-Medicine (CAMP) as part of Singapore's National Cell Manufacturing Initiative

Potential cancer treatment strategies for humans from mechanisms behind low cancer occurrence in bats.

A new study reveals that a protein present in higher amounts in bats compared to humans may contribute to their low cancer incidence.

Singapore scientists uncover mechanism behind development of viral infections

Clinical trial findings provide new insights to differential responses to flaviviral infections.

Exosomes found to aid in fighting Dengue infection New area for exosome research shows potential therapeutic strategy for treating Dengue Fever.
National platforms created to accelerate Singapore's drug development efforts

Collaborations between research institutions and healthcare providers look to enhance the competitive edge in drug discovery for Singapore's biomedical ecosystem.

REST OF THE WORLD
Cybersecurity company threat report details cyberattacks targeting the healthcare industry

Report highlights input from 20 leading healthcare Chief Information Security Officers (CISOs) who offer their perspective on evolving cyberattacks, ransomware and the biggest concerns to their organizations.

Artificial intelligence - designed influenza vaccine begins clinical trials in the US

More effective seasonal flu vaccine to be tested in clinical trials.

Clinical - stage biotechnology company presents Murlentamab phase II study results in colorectal cancer.

GamaMabs Pharma, developing optimized therapeutic antibodies targeting the Anti-Müllerian Hormone Receptor II (AMHRII) for the treatment of cancer, announces the oral presentation of clinical data from its phase II study of murlentamab in metastatic colorectal cancer (mCRC)

NEWS CRUNCH  
news The Proteona Oncology Challenge using ESCAPETM Single Cell Proteogenomic Analysis
news New computational fluid dynamics solution for modeling aerosol mixtures in biomedical and environmental research
news Medial Fair Thailand opened on 11th September 2019 with a focus on future-proofing Thailand's healthcare industry to meet the challenges and opportunities of the next decade
news Biofuel Producers and Users to Convene in Singapore for Global Biofuels Summit
PR NEWSWIRE  
Asia Pacific Biotech News
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
October:
Disruptive Urban Farming — Microbes, Plasmids, and Recycling
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy